2-149571135-G-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_015702.3(MMADHC):​c.646C>G​(p.Arg216Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00162 in 1,612,120 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 10 hom. )

Consequence

MMADHC
NM_015702.3 missense

Scores

8
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:6

Conservation

PhyloP100: 1.40

Publications

5 publications found
Variant links:
Genes affected
MMADHC (HGNC:25221): (metabolism of cobalamin associated D) This gene encodes a mitochondrial protein that is involved in an early step of vitamin B12 metabolism. Vitamin B12 (cobalamin) is essential for normal development and survival in humans. Mutations in this gene cause methylmalonic aciduria and homocystinuria type cblD (MMADHC), a disorder of cobalamin metabolism that is characterized by decreased levels of the coenzymes adenosylcobalamin and methylcobalamin. Pseudogenes have been identified on chromosomes 11 and X.[provided by RefSeq, Nov 2008]
MMADHC Gene-Disease associations (from GenCC):
  • inborn disorder of cobalamin metabolism and transport
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • methylmalonic aciduria and homocystinuria type cblD
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0128771365).
BP6
Variant 2-149571135-G-C is Benign according to our data. Variant chr2-149571135-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 203837.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00176 (268/152286) while in subpopulation NFE AF = 0.00275 (187/68016). AF 95% confidence interval is 0.00243. There are 0 homozygotes in GnomAd4. There are 128 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015702.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MMADHC
NM_015702.3
MANE Select
c.646C>Gp.Arg216Gly
missense
Exon 7 of 8NP_056517.1Q9H3L0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MMADHC
ENST00000303319.10
TSL:1 MANE Select
c.646C>Gp.Arg216Gly
missense
Exon 7 of 8ENSP00000301920.5Q9H3L0
MMADHC
ENST00000934249.1
c.769C>Gp.Arg257Gly
missense
Exon 8 of 9ENSP00000604308.1
MMADHC
ENST00000422782.2
TSL:5
c.748C>Gp.Arg250Gly
missense
Exon 8 of 9ENSP00000408331.2F8WEC0

Frequencies

GnomAD3 genomes
AF:
0.00175
AC:
267
AN:
152168
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00481
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00275
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00198
AC:
497
AN:
250912
AF XY:
0.00199
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000696
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00591
Gnomad NFE exome
AF:
0.00264
Gnomad OTH exome
AF:
0.00229
GnomAD4 exome
AF:
0.00161
AC:
2348
AN:
1459834
Hom.:
10
Cov.:
30
AF XY:
0.00167
AC XY:
1216
AN XY:
726248
show subpopulations
African (AFR)
AF:
0.0000897
AC:
3
AN:
33454
American (AMR)
AF:
0.000627
AC:
28
AN:
44656
Ashkenazi Jewish (ASJ)
AF:
0.00184
AC:
48
AN:
26082
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39548
South Asian (SAS)
AF:
0.000430
AC:
37
AN:
86020
European-Finnish (FIN)
AF:
0.00608
AC:
324
AN:
53322
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5762
European-Non Finnish (NFE)
AF:
0.00164
AC:
1824
AN:
1110738
Other (OTH)
AF:
0.00136
AC:
82
AN:
60252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
112
224
336
448
560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00176
AC:
268
AN:
152286
Hom.:
0
Cov.:
32
AF XY:
0.00172
AC XY:
128
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41556
American (AMR)
AF:
0.000719
AC:
11
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3466
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4828
European-Finnish (FIN)
AF:
0.00481
AC:
51
AN:
10606
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00275
AC:
187
AN:
68016
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
15
29
44
58
73
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00321
Hom.:
0
Bravo
AF:
0.00113
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.00192
AC:
233

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
Methylmalonic aciduria and homocystinuria type cblD (3)
-
1
1
not specified (2)
-
-
1
Disorders of Intracellular Cobalamin Metabolism (1)
-
-
1
MMADHC-related disorder (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.060
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.72
D
Eigen
Benign
0.024
Eigen_PC
Benign
0.072
FATHMM_MKL
Benign
0.66
D
LIST_S2
Uncertain
0.96
D
M_CAP
Benign
0.082
D
MetaRNN
Benign
0.013
T
MetaSVM
Uncertain
-0.053
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
1.4
PrimateAI
Benign
0.37
T
PROVEAN
Uncertain
-2.8
D
REVEL
Uncertain
0.48
Sift
Benign
0.27
T
Sift4G
Benign
0.38
T
Polyphen
0.31
B
Vest4
0.49
MVP
0.80
MPC
0.083
ClinPred
0.037
T
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.32
gMVP
0.41
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141093638; hg19: chr2-150427649; COSMIC: COSV106101584; API